Skip to main content

Cel Sci Corp

CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000725363

In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Cel Sci Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of CVM: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders7876−2
Shares6.46M5.86M−606.6K (−9.4%)
Value$20.0M$13.8M−$6.23M (−31.2%)

New holders (14)

Institutions that held Cel Sci Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to CVM in Q4 2022
InstitutionSharesValue% of portfolio
Virtu Financial LLC56,020$132.0K0.02%
Jane Street Group, LLC31,190$73.3K0.00%
True Capital Management12,376$29.1K0.02%
Nations Financial Group Inc,11,500$27.0K0.00%
Two Sigma Investments, LP11,225$26.4K0.00%
Verition Fund Management LLC10,100$23.7K0.00%
Cary Street Partner Investment Advisory LLC1,500$3.52K0.00%
City State Bank1,000$2.00K0.00%
Northwestern Mutual Wealth Management Co539$1.27K0.00%
Global Wealth Strategies & Associates500$1.18K0.00%
Advisory Services Network, LLC300$7050.00%
Money Concepts Capital Corp40$940.00%
BBJS Financial Advisors, LLC40$940.00%
GWM Advisors LLC1,500$40.00%

Sold out (16)

Institutions that held Cel Sci Corp at the end of Q3 2022 and filed for Q4 2022 without it.